1-5 of 5
Tanya Paris
Close
Sort by
Journal Articles

Double Expressing (MYC/BCL2) and Double-Hit Diffuse Large B-Cell Lymphomas Have Inferior Survival Following Autologous Stem Cell Transplantation

Alex F. Herrera, MD, Matthew G. Mei, MD, Lawrence Low, MD PhD, Reid W. Merryman, MD, Joo Y. Song, MD, Tanya Paris, Tracey Stiller, Victoria Bedell, Heather Sun, Jennifer R. Brown, MD PhD, Lihua Elizabeth Budde, MD PhD, Robert Chen, Matthew S. Davids, MD, Arnold S. Freedman, MD, David C. Fisher, MD, Eric D. Jacobsen, MD, Caron A. Jacobson, MD, Haesook T. Kim, PhD, Ann S. LaCasce, MD, Joyce Murata-Collins, PhD, Auayporn P. Nademanee, MD, Joycelynne Palmer, PhD, German A. Pihan, MD, Tanya Siddiqi, MD, Aliyah R Sohani, MD, Leslie L. Popplewell, MD, Jasmine Zain, MD, Larry W. Kwak, MD, David M. Weinstock, Stephen J. Forman, MD, Dennis D. Weisenburger, MD, Young Kim, MD, Scott J. Rodig, MD, PhD, Amrita Krishnan, Philippe Armand, MD PhD
Journal: Blood
Blood (2015) 126 (23): 522.
https://doi.org/10.1182/blood.V126.23.522.522
Published: 2015
Journal Articles

Hypercvad Induction Chemotherapy Is Associated with Higher Rates of Stem Cell Mobilization Failure in Mantle Cell Lymphoma ( MCL)

Amandeep Salhotra, MD, Shan Yuan, MD, Joycelynne Palmer, PhD, Ibrahim Aldoss, MD, Ni-Chun Tsai, MS MPH, Tanya Paris, Stephen J. Forman, MD, Robert W Chen, MD
Journal: Blood
Blood (2014) 124 (21): 3849.
https://doi.org/10.1182/blood.V124.21.3849.3849
Published: 2014
Journal Articles

Brentuximab Vedotin Improves HCT-CI, CR Status, and Peri-Transplant Toxicity In Patients With Relapsed/Refractory Hodgkin Lymphoma Heading To RIC Allo-HCT

Robert Chen, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS MPH, Sandra H. Thomas, PhD, Tanya Paris, Leslie Popplewell, MD, Chatchada Karanes, MD, Tanya Siddiqi, MD, Auayporn Nademanee, MD, Ji-Lian Cai, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2013) 122 (21): 3374.
https://doi.org/10.1182/blood.V122.21.3374.3374
Published: 2013
Journal Articles

Analysis of Risk Factors and Outcome for Extramedullary Relapses Post Allogeneic Stem Cell Transplantation for Myeloma.

Myo Htut, MD, Firoozeh Sahebi, M.D., George Somlo, MD, Pablo Parker, M.D., Chatchada Karanes, MD, Andy Dagis, Susan Hmwe, Tanya Paris, Joyce Murata-Collins, PhD, Leslie Popplewell, M.D., Joycelynne Palmer, PhD., Stephen Forman, M.D., Amrita Krishnan, M.D.
Journal: Blood
Blood (2010) 116 (21): 4562.
https://doi.org/10.1182/blood.V116.21.4562.4562
Published: 2010
Journal Articles

HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for B Cell Non Hodgkin Lymphoma (NHL).

Amrita Krishnan, MD, FACP, John Zaia, MD, Joseph Alvarnas, MD, Neil Kogut, MD, Ricardo Spielberger, MD, Michelle Wardlow, RN, Nicole Tsai, MS, Tanya Paris, BS, Stephen J Forman, MD
Journal: Blood
Blood (2008) 112 (11): 2181.
https://doi.org/10.1182/blood.V112.11.2181.2181
Published: 2008